Tetraethylammonium: Clinical Trials

1 trial of Tetraethylammonium, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Tetraethylammonium: new trials by email Literature Review of Tetraethylammonium trials Research Report on Tetraethylammonium

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Endothelial Hyperpolarization in Humans
Tetraethylammonium (TEA), L-NG-monomethyl Arginine (L-NMMA), Bradykinin - Hyperlipidemia
Phase 2TerminatedEmory University1742002-07-012018-08-15

Conditions studied

Hyperlipidemias (1)

Sponsors

Emory University (1)

Countries

United States (1)

Top investigators

Arshed A Quyyumi, MD (1)

Results publications

PMID 21555712, PMID 24675657, PMID 24925526, PMID 25648989

NIH funding

R01HL079115 (1)